Dormant
WIX · Wix.com Ltd.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 7 August 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-08-21 at medium conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.
Current thesis
Base44 margin inversion is the live leg and the market is now paying up for it: after the 2026-08-04 beat ($563.1M, +15%; adj EPS $1.39 vs $1.16) and the ~60% 2H gross-margin guide, price ran from the 2026-08-07 close of $60.20 to $66.14 on 2026-08-11, far above the $51.56 50-day. No company proof point until the ~November print, and a securities class action over Base44 cost disclosure has a 2026-09-22 lead-plaintiff deadline in between.
Kill line
A weekly close below $52 fills the 2026-08-04 earnings gap and returns price to the pre-print base, which now overlaps the rising 50-day average at $51.56; secondary, Q3 bookings growth printing under Q2's +12% or an FY26 cut from low-teens bookings growth.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for WIX —
As of 20 September 2026, the latest FrontierPicks analysis for Wix.com Ltd. (WIX): Base44 margin inversion is the live leg and the market is now paying up for it: after the 2026-08-04 beat ($563.1M, +15%; adj EPS $1.39 vs $1.16) and the ~60% 2H gross-margin guide, price ran from the 2026-08-07 close of $60.20 to $66.14 on 2026-08-11, far above the $51.56 50-day. No company proof point until the ~November print, and a securities class action over Base44 cost disclosure has a 2026-09-22 lead-plaintiff deadline in between.
Kill line: A weekly close below $52 fills the 2026-08-04 earnings gap and returns price to the pre-print base, which now overlaps the rising 50-day average at $51.56; secondary, Q3 bookings growth printing under Q2's +12% or an FY26 cut from low-teens bookings growth.
Next dated event on file: — catalyst in 2d.
Current Thesis
Wix.com's recovery rests on Base44 converting artificial-intelligence demand into better margins; reported second-half margins near management's approximately 60% forecast would substantiate the story, while a weekly close below $52 would invalidate the price-recovery thesis. Management made that forecast on 2026-08-04, attributing lower computing costs to Base44's proprietary large language model, Base 1. The forecast remains a management expectation, not a reported second-half result. Wix results filed with the SEC.
The latest measured change is the market reference close: $78.49 on 2026-09-18, compared with $76.21 on 2026-09-04 and the previously documented $82.07 close on 2026-08-21. The narrative is maturing — an inference from the 2026-08-04 margin announcement remaining the operating test while the latest close remains below that August reference. These observations do not establish that participation has broadened or that demand for the shares is exhausted.
The case would play out through reported Base44 second-half non-GAAP gross margin near 60% and a weekly close above the documented $82.07 reference before the $52 invalidation fires. The evidence supports medium conviction: the revenue result is measured, but the margin outcome remains prospective.
Bullish and bearish views on Wix.com Ltd.
The model's bull view on Wix.com Ltd. (WIX), in brief: Revenue growth supports the transition. Wix reported second-quarter revenue of $563.1 million, up 15% year over year, on 2026-08-04. That establishes company-level growth alongside the Base44 investment, without attributing all growth to the newer business. Wix quarterly… The bear view: Bookings trail reported revenue growth. The 2026-08-04 release showed second-quarter bookings growth of 12%, against revenue growth of 15%, and identified weakness among Partners. A reduction in the reaffirmed full-year low-teens bookings-growth outlook would confirm… Both cases follow in full.
Bull Case
- Revenue growth supports the transition. Wix reported second-quarter revenue of $563.1 million, up 15% year over year, on 2026-08-04. That establishes company-level growth alongside the Base44 investment, without attributing all growth to the newer business. Wix quarterly release.
- Margin improvement has a mechanism. On 2026-08-04, management linked its approximately 60% second-half Base44 non-GAAP gross-margin forecast to Base 1 and greater control of computing costs. Withdrawal of that forecast would defeat this operating premise. Wix quarterly release.
Bear Case
- Bookings trail reported revenue growth. The 2026-08-04 release showed second-quarter bookings growth of 12%, against revenue growth of 15%, and identified weakness among Partners. A reduction in the reaffirmed full-year low-teens bookings-growth outlook would confirm deterioration beyond the existing forecast. Wix quarterly release.
- Savings also fund marketing spending. Management's 2026-08-04 outlook explicitly planned to reinvest computing savings in Base44 marketing. Better unit margins therefore do not establish an equivalent improvement in consolidated cash generation. Wix quarterly release.
- Disclosure allegations remain unresolved. Hagens Berman's 2026-09-19 notice repeated the 2026-09-22 lead-plaintiff deadline in the securities case concerning AI-related disclosures. The notice supplies allegations and a procedural date, not a judicial finding about Base44 economics. Dated law-firm notice.
Setup & Price Structure
The supplied adjusted market series records a $78.49 close and a 14-day relative strength index (RSI) of 35.7 on 2026-09-18. The close remains below the documented 2026-08-21 close of $82.07. A weekly close above that reference would satisfy the price component of the recovery case; a weekly close below $52 would end it. Neither reference establishes a newly formed support shelf.
Stock Analysis displayed an average analyst target of $78.45 across 22 analysts when reviewed on 2026-09-20, close to the supplied September 18 market close. This is a vendor-specific consensus, not evidence of a valuation ceiling or a forecast of the next price move. Stock Analysis analyst survey.
Current short interest, trading-volume participation and moving averages are missing from the September 18 evidence. The September 6 observations cannot establish current crowding or the distance above a currently rising average. The isolated retail retrospective dated 2026-09-02 in the earlier coverage is too small a sample to support a claim of widespread retail saturation.
Catalyst Calendar (next 30 days)
- 2026-09-22 — Lead-plaintiff application deadline. Hagens Berman reaffirmed this date on 2026-09-19. It concerns litigation procedure; it does not schedule an operating disclosure or a ruling on the allegations. September 19 notice.
- ~2026-11-18, estimated — Third-quarter results. MarketBeat's calendar reviewed on 2026-09-20 lists this later date; company confirmation is unavailable. The report would test progress toward the second-half margin forecast, although a third-quarter result alone would not settle the full second-half outcome. MarketBeat calendar.
What Would Change Our Mind
Failure of the post-August recovery is defined by a weekly close below $52, retaining the research boundary published on 2026-09-06. No current moving-average claim is attached to that level. Separately, withdrawal of the approximately 60% second-half Base44 margin forecast announced on 2026-08-04 would remove the operating premise; a full-year bookings-guidance cut would weaken the supporting growth case.
Reported second-half margins near management's forecast, together with a weekly close above the 2026-08-21 reference of $82.07 before invalidation, would substantiate the case. A product announcement without reported economics would leave that test unresolved.
Correlation Notes
This remains a single-company thesis: the dated operating condition is Wix's 2026-08-04 Base44 margin forecast. The 2026-08-14 Benzinga report associated Wix's decline with a broader technology decline, but one session is too small a sample to establish a stable software-sector correlation. No current return series supports a numerical correlation claim or attribution of the September 18 close to a group move.
Notes
- Israeli foreign private issuer: files 20-F/6-K rather than 10-Q/10-K, and insiders are Section 16 exempt, so Form 4 insider screens return nothing on this name.
- Share count fell ~29.7% via the tender completed 2026-04-03 at $92.00; per-share comparisons spanning that date are not like-for-like.
- Vendor short-percentage fields do not reconcile here: the 2026-09-06 page shows 5.78M short shares alongside a 17.07% short-of-outstanding figure against 41.85M shares outstanding.
- Capital structure includes 0.00% convertible senior notes due 2030, which the $2.0B board authorization may repurchase alongside ordinary shares.
- GAAP and non-GAAP diverge materially: Q2 2026 showed a $(76.4)M GAAP net loss against $68.2M non-GAAP net income.
- The N.D. Ill. Securities class action covers purchasers 2025-02-19 to 2026-05-12; allegations are unadjudicated and no lead plaintiff has been appointed.
Related · shared themes
APPN
Appian Corporation
Appian’s AI orchestration re-rating needs Q3 revenue of at least $214 million and cloud subscriptions of at least $133 million to confirm management’s August guidance. A weekly close below $34 or a miss against either revenue floor invalidates the case.
CRM
Salesforce, Inc.
De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions between 2026-08-12 and 2026-08-20 chased price to $209.17; the 2026-08-26 Q2 FY27 print is the binary and much of the discount closed before it.
CRWD
CrowdStrike Holdings, Inc.
Fal.Con (2026-08-31 to 09-03) delivered real product — Falcon Guardian, Falcon IQ, GPT-5.6 Cyber in Falcon, Anthropic marketplace distribution — and nine broker actions through 2026-09-04 including Truist $300, yet CRWD closed $213.10 on 2026-09-04, below the $218.40 of 08-28 and the $233.88 range high. The catalyst is spent and no company-dated event lands before the ~2026-12-02 Q3 print, leaving a maturing narrative carried by targets rather than a widening bid.
FROG
JFrog Ltd.
Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June. Fundamentals accelerating (Q1 rev +26%, security 10% of ARR), but a fresh long is extended near 52-week highs with the ~Aug 6 Q2 print the next binary.